Regents of the University of California’s Caribou Biosciences CRBU Stock Holding History

Regents of the University of California’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-90,652	Closed	-$385K	–	29
2023 Q2	$385K	Hold	90,652	–	–	0.05%	24
2023 Q1	$481K	Hold	90,652	–	–	0.09%	22
2022 Q4	$569K	Hold	90,652	–	–	0.11%	22
2022 Q3	$956K	Sell	90,652 -90,652	-50%	-$845K	0.19%	20
2022 Q2	$984K	Hold	181,304	–	–	0.2%	20
2022 Q1	$1.66M	Buy	+181,304	New	+$1.91M	0.25%	20

Other funds holding CRBU

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Regents of the University of California's CRBU Position: Q3 2023 in Review

Regents of the University of California sold out of Caribou Biosciences (CRBU) in Q3 2023, closing a stake of 90,652 shares — an estimated $385K sold.

Regents of the University of California first reported a position in CRBU in Q1 2022 and held it in 6 quarters. The position peaked at $1.66M in Q1 2022. 126 funds tracked by Wall St. Rank hold CRBU as of Q3 2023.

Regents of the University of California reported no remaining Caribou Biosciences position as of Q3 2023 after selling out during the quarter.
Regents of the University of California sold 90,652 Caribou Biosciences shares in Q3 2023, an estimated $385K.
Regents of the University of California first reported a position in Caribou Biosciences in Q1 2022 and held it in 6 quarters.
Regents of the University of California's Caribou Biosciences position peaked at $1.66M in Q1 2022.
126 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2023.

Based on Regents of the University of California's 13F filing for Q3 2023, filed 12 Oct 2023.